Trial Profile
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2010
Price :
$35
*
At a glance
- Drugs Azimilide (Primary)
- Indications Atrial fibrillation
- Focus Registrational; Therapeutic Use
- Sponsors Procter & Gamble
- 30 Mar 2010 New trial record